Cytokine Storm among Bangladeshi adults with COVID-19: A prospective cohort study

Monira Sarmin1,2, Fhameda Akter1, Anika Nawrin Islam1

  • 1Clinical and Diagnostic Services, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Heliyon
|December 10, 2024
PubMed

Insights

Cytokine storms (CS) significantly impact COVID-19 outcomes. In Bangladeshi adults, 37.5% of COVID-19 patients experienced CS, highlighting a critical public health concern during the pandemic.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Cytokine storms (CS) are linked to increased mortality and morbidity in COVID-19 patients.
  • Understanding the prevalence of CS in specific populations is crucial for effective management.

Purpose of the Study:

  • To evaluate the incidence rate of cytokine storms among COVID-19 positive adults in Bangladesh.
  • To analyze cytokine profiles and their correlation with disease severity and outcomes.

Main Methods:

  • A cohort study conducted from October 2020 to March 2022, including COVID-positive and COVID-negative adults.
  • Cytokine storm defined by IL-6 levels >80 pg/mL or specific combinations of elevated CRP, ferritin, LDH, D-dimer, or low lymphocytes.
  • Plasma samples analyzed for IL-6, IL-1β, and TNF-α levels.

Main Results:

  • The study included 77 participants: 32 severe-critical, 30 mild-moderate COVID-19, and 14 COVID-negative.
  • A cytokine storm rate of 37.5% (12/32) was observed in the severe-critical COVID-19 group.
  • COVID-19 positive patients exhibited higher IL-6 levels compared to controls, with IL-6 correlating positively with CRP.

Conclusions:

  • Bangladeshi adults faced a notable rate of cytokine storms during the COVID-19 pandemic.
  • The findings underscore the significant burden of cytokine storms in this population, necessitating targeted interventions.
Abstract